News

A rare gene mutation that delays Alzheimer’s disease does so by damping inflammatory signaling in brain-resident immune cells, according to a preclinical study led by investigators at Weill Cornell Medicine. 

The INSIGHT Clinical Research Network (CRN), a database of more than 23 million patient health records, has received $13.5 million in renewed funding from the Patient-Centered Outcomes Research Institute.

 A study led by Weill Cornell Medicine investigators has found that immune tolerance to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. 

Dr. Teresa Sanchez, associate professor of pathology and laboratory medicine and associate professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, has been awarded the highly competitive Established Investigator Award from the American Heart Association.

Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports how we think and act.

The Weill Award recognizes an exceptional faculty member whose transformational work enhances health care worldwide. 

Dr. Arnab Ghosh, assistant professor of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine Scholar.

The award recognizes exceptional junior investigators for their notable research achievements, impactful findings and high potential for success as independent investigators.

At the 12th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium, scientists and clinicians shared their latest research which is advancing how Alzheimer’s disease is diagnosed and treated. 

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

A new study from researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.

Awards, honors and achievements for the month of May.

Dr. Juan R. Cubillos-Ruiz and Dr. David Lyden have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings.

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, for years sometimes.

On May 15, Weill Cornell Medicine honored Class of 2025 graduates from Weill Cornell Medical College and the Weill Cornell Graduate School.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care May 14-15 during Weill Cornell Medicine’s commencement activities.

Medical and physician assistant students from the Class of 2025 were honored during convocation and certificate ceremonies May 14 for their dedication to scholarship, excellence in research, devotion to teaching or service and exceptional professional qualities.

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2025 for their academic achievements during its convocation ceremony on May 14.